Literature DB >> 26436913

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection.

Jay D Raman1, Kathleen K Lehman2, Kalyan Dewan3, Girish Kirimanjeswara3.   

Abstract

Single institution and population-based studies highlight that infectious complications following transrectal ultrasound guided prostate needle biopsy (TRUS PNB) are increasing. Such infections are largely attributable to quinolone resistant microorganisms which colonize the rectal vault and are translocated into the bloodstream during the biopsy procedure. A povidone iodine rectal preparation (PIRP) at time of biopsy is a simple, reproducible method to reduce rectal microorganism colony counts and therefore resultant infections following TRUS PNB. All patients are administered three days of oral antibiotic therapy prior to biopsy. The PIRP technique involves initially positioning the patient in the standard manner for a TRUS PNB. Following digital rectal examination, 15 ml of a 10% solution of commercially available povidone iodine is mixed with 5 ml of 1% lidocaine jelly to create slurry. A 4 cmx4 cm sterile gauze is soaked in this slurry and then inserted into the rectal vault for 2 min after which it is removed. Thereafter, a disposable cotton gynecologic swab is used to paint both the perianal area and the rectal vault to a distance of 3 cm from the anus. The povidone iodine solution is then allowed to dry for 2-3 min prior to proceeding with standard transrectal ultrasonography and subsequent biopsy. This PIRP technique has been in practice at our institution since March of 2012 with an associated reduction of post-biopsy infections from 4.3% to 0.6% (p=0.02). The principal advantage of this prophylaxis regimen is its simplicity and reproducibility with use of an easily available, inexpensive agent to reduce infections. Furthermore, the technique avoids exposing patients to additional systemic antibiotics with potential further propagation of multi-drug resistant organisms. Usage of PIRP at TRUS PNB, however, is not applicable for patients with iodine or shellfish allergies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26436913      PMCID: PMC4692615          DOI: 10.3791/52670

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

Review 1.  Genitourinary imaging: current and emerging applications.

Authors:  P M O' Donoghue; S E McSweeney; K Jhaveri
Journal:  J Postgrad Med       Date:  2010 Apr-Jun       Impact factor: 1.476

2.  Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate.

Authors:  Justin R Gyorfi; Christopher Otteni; Kevin Brown; Amar Patel; Kathleen Lehman; Brett E Phillips; Kalyan Dewan; Girish Kirimanjeswara; Jay D Raman
Journal:  World J Urol       Date:  2014-03-30       Impact factor: 4.226

3.  Control of infective complications of transrectal prostate biopsy.

Authors:  Dong Soo Park; Jin Ho Hwang; Don Kyung Choi; In Hyuck Gong; Young Kwon Hong; Sujin Park; Jong Jin Oh
Journal:  Surg Infect (Larchmt)       Date:  2014-05-19       Impact factor: 2.150

4.  Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.

Authors:  Aisha K Taylor; Teresa R Zembower; Robert B Nadler; Marc H Scheetz; John P Cashy; Diana Bowen; Adam B Murphy; Elodi Dielubanza; Anthony J Schaeffer
Journal:  J Urol       Date:  2012-02-16       Impact factor: 7.450

5.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

Authors:  Robert K Nam; Refik Saskin; Yuna Lee; Ying Liu; Calvin Law; Laurence H Klotz; D Andrew Loblaw; John Trachtenberg; Aleksandra Stanimirovic; Andrew E Simor; Arun Seth; David R Urbach; Steven A Narod
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

6.  The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?

Authors:  Joseph Feliciano; Ervin Teper; Michael Ferrandino; Richard J Macchia; William Blank; Ivan Grunberger; Ivan Colon
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

7.  A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy.

Authors:  Zeid Abughosh; Joseph Margolick; S Larry Goldenberg; Stephen A Taylor; Kourosh Afshar; Robert Bell; Dirk Lange; William R Bowie; Diane Roscoe; Lindsay Machan; Peter C Black
Journal:  J Urol       Date:  2012-10-02       Impact factor: 7.450

8.  Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate.

Authors:  Elijah O Kehinde; May Al-Maghrebi; Mehraj Sheikh; Jehoram T Anim
Journal:  J Urol       Date:  2012-09-23       Impact factor: 7.450

9.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

Authors:  K K Hodge; J E McNeal; M K Terris; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

10.  Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy.

Authors:  Dong Soo Park; Jong Jin Oh; Jin Ha Lee; Woong Ki Jang; Young Kwon Hong; Sung Keun Hong
Journal:  Adv Urol       Date:  2009-04-23
  10 in total
  2 in total

1.  Topical rectal antiseptic at time of prostate biopsy: how a resident patient safety project has evolved into institutional practice.

Authors:  Rosa Park; Justin Gyorfi; Kalyan Dewan; Girish Kirimanjeswara; Joseph Y Clark; Matthew G Kaag; Kathleen Lehman; Jay D Raman
Journal:  Int Urol Nephrol       Date:  2018-07-17       Impact factor: 2.370

2.  Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship.

Authors:  Shayann Ramedani; Joseph Y Clark; John J Knoedler; Susan MacDonald; Matthew G Kaag; Suzanne B Merrill; Jay D Raman
Journal:  Prostate Int       Date:  2021-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.